Your browser doesn't support javascript.
loading
A Case of Prurigo Nodularis Treated with Dupilumab / 대한피부과학회지
Article in En | WPRIM | ID: wpr-968043
Responsible library: WPRO
ABSTRACT
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by multiple nodules and papules, which are accompanied by intense pruritus. Treatment is challenging and requires a diverse approach. Recently, a few reports have described successful treatment of PN with dupilumab. We report a case of a patient with treatment-resistant PN who was successfully treated with dupilumab. Dupilumab was administered at the standard dose an initial induction dose of 600 mg, followed by 300 mg every 14 days. Pruritus reduced after 2 weeks and almost completely disappeared after 4 weeks of treatment.
Full text: 1 Index: WPRIM Language: En Journal: Korean Journal of Dermatology Year: 2022 Type: Article
Full text: 1 Index: WPRIM Language: En Journal: Korean Journal of Dermatology Year: 2022 Type: Article